Performance

KLRA -47.31%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
KLRA	+5.63%	-47.31%*	-47.31%*	—	-61.54%*	-1.25*	0.00%*

Summary

KLRA at a glance

KLRA returned -47.31% since Apr 17, 2026. Its worst drop since then was -61.54%, smaller than 11% of stocks on Redstone, and its Sharpe ratio of -1.25 beats 2% of stocks on Redstone. It hasn't paid a dividend since it listed.

Ranking

How KLRA ranks

Dividend Yield Rank *

Current Drawdown

-47.31%

Rolling Volatility

74.99%

Actions

Metrics

Risk Indicators*

Alpha-101.78%

Beta1.27x

Sharpe-1.25

Sortino-1.73

Omega0.82

Calmar-0.77

Martin-2.54

Profile

About KLRA

Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $1.8B
Listed: Apr 2026
Headquarters: Waltham, MA
Website: kailera.com

Comparisons

KLRA: Kailera Therapeutics, Inc.

KLRA at a glance

How KLRA ranks

Current Drawdown

Rolling Volatility

About KLRA

Related comparisons